nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—HTR1D—meninx—intracranial aneurysm	0.0913	0.0979	CbGeAlD
Olanzapine—HTR1B—dura mater—intracranial aneurysm	0.0868	0.093	CbGeAlD
Olanzapine—HTR1D—dura mater—intracranial aneurysm	0.0841	0.0901	CbGeAlD
Olanzapine—HTR2C—choroid plexus—intracranial aneurysm	0.0708	0.0758	CbGeAlD
Olanzapine—HTR1B—trigeminal nerve—intracranial aneurysm	0.0373	0.04	CbGeAlD
Olanzapine—HTR1D—trigeminal nerve—intracranial aneurysm	0.0361	0.0387	CbGeAlD
Olanzapine—HTR2A—choroid plexus—intracranial aneurysm	0.0355	0.038	CbGeAlD
Olanzapine—HTR3A—cranial nerve—intracranial aneurysm	0.0317	0.034	CbGeAlD
Olanzapine—HTR1B—cranial nerve—intracranial aneurysm	0.0266	0.0285	CbGeAlD
Olanzapine—HTR7—vein—intracranial aneurysm	0.026	0.0279	CbGeAlD
Olanzapine—HTR1D—cranial nerve—intracranial aneurysm	0.0257	0.0276	CbGeAlD
Olanzapine—HTR7—cranial nerve—intracranial aneurysm	0.0205	0.022	CbGeAlD
Olanzapine—HTR7—pons—intracranial aneurysm	0.0203	0.0217	CbGeAlD
Olanzapine—HTR2A—trigeminal nerve—intracranial aneurysm	0.018	0.0192	CbGeAlD
Olanzapine—HTR2A—vein—intracranial aneurysm	0.0162	0.0174	CbGeAlD
Olanzapine—HTR1B—artery—intracranial aneurysm	0.0137	0.0147	CbGeAlD
Olanzapine—HTR1D—artery—intracranial aneurysm	0.0133	0.0143	CbGeAlD
Olanzapine—HTR2A—cranial nerve—intracranial aneurysm	0.0128	0.0137	CbGeAlD
Olanzapine—HTR2A—pons—intracranial aneurysm	0.0126	0.0135	CbGeAlD
Olanzapine—HTR1E—brainstem—intracranial aneurysm	0.0124	0.0133	CbGeAlD
Olanzapine—HTR5A—brain—intracranial aneurysm	0.0116	0.0124	CbGeAlD
Olanzapine—HTR7—artery—intracranial aneurysm	0.0106	0.0114	CbGeAlD
Olanzapine—DRD1—brainstem—intracranial aneurysm	0.00722	0.00774	CbGeAlD
Olanzapine—HTR3A—brainstem—intracranial aneurysm	0.00697	0.00747	CbGeAlD
Olanzapine—HTR2A—artery—intracranial aneurysm	0.00661	0.00708	CbGeAlD
Olanzapine—HTR1B—brainstem—intracranial aneurysm	0.00585	0.00627	CbGeAlD
Olanzapine—DRD4—brain—intracranial aneurysm	0.00575	0.00616	CbGeAlD
Olanzapine—HTR1D—brainstem—intracranial aneurysm	0.00567	0.00607	CbGeAlD
Olanzapine—HTR2C—brainstem—intracranial aneurysm	0.00561	0.00601	CbGeAlD
Olanzapine—H1F0—medulla oblongata—intracranial aneurysm	0.0051	0.00546	CbGeAlD
Olanzapine—HTR1E—brain—intracranial aneurysm	0.00495	0.00531	CbGeAlD
Olanzapine—HTR1A—brainstem—intracranial aneurysm	0.00472	0.00506	CbGeAlD
Olanzapine—H1F0—midbrain—intracranial aneurysm	0.00466	0.00499	CbGeAlD
Olanzapine—DRD1—midbrain—intracranial aneurysm	0.0046	0.00493	CbGeAlD
Olanzapine—HTR7—brainstem—intracranial aneurysm	0.00451	0.00484	CbGeAlD
Olanzapine—ADRA1A—brainstem—intracranial aneurysm	0.00435	0.00466	CbGeAlD
Olanzapine—CHRM4—brain—intracranial aneurysm	0.00434	0.00465	CbGeAlD
Olanzapine—DRD2—brainstem—intracranial aneurysm	0.00427	0.00457	CbGeAlD
Olanzapine—DRD3—brain—intracranial aneurysm	0.00404	0.00433	CbGeAlD
Olanzapine—FMO3—brain—intracranial aneurysm	0.00399	0.00428	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—intracranial aneurysm	0.00391	0.00419	CbGeAlD
Olanzapine—HTR6—brain—intracranial aneurysm	0.00389	0.00417	CbGeAlD
Olanzapine—DRD5—brain—intracranial aneurysm	0.00378	0.00406	CbGeAlD
Olanzapine—HTR1B—midbrain—intracranial aneurysm	0.00373	0.004	CbGeAlD
Olanzapine—HTR1D—midbrain—intracranial aneurysm	0.00361	0.00387	CbGeAlD
Olanzapine—H1F0—cerebellum—intracranial aneurysm	0.00361	0.00386	CbGeAlD
Olanzapine—HTR2C—midbrain—intracranial aneurysm	0.00358	0.00383	CbGeAlD
Olanzapine—HRH2—brain—intracranial aneurysm	0.00355	0.00381	CbGeAlD
Olanzapine—CHRM5—brain—intracranial aneurysm	0.0034	0.00364	CbGeAlD
Olanzapine—HTR7—medulla oblongata—intracranial aneurysm	0.00315	0.00337	CbGeAlD
Olanzapine—ADRA1B—brain—intracranial aneurysm	0.0031	0.00332	CbGeAlD
Olanzapine—HTR1A—midbrain—intracranial aneurysm	0.00301	0.00322	CbGeAlD
Olanzapine—H1F0—brain—intracranial aneurysm	0.00293	0.00314	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—intracranial aneurysm	0.00289	0.0031	CbGeAlD
Olanzapine—DRD1—brain—intracranial aneurysm	0.00289	0.0031	CbGeAlD
Olanzapine—HTR7—midbrain—intracranial aneurysm	0.00288	0.00308	CbGeAlD
Olanzapine—HTR2A—brainstem—intracranial aneurysm	0.00281	0.00302	CbGeAlD
Olanzapine—HTR3A—brain—intracranial aneurysm	0.00279	0.00299	CbGeAlD
Olanzapine—DRD2—midbrain—intracranial aneurysm	0.00272	0.00291	CbGeAlD
Olanzapine—ADRA2C—midbrain—intracranial aneurysm	0.00264	0.00283	CbGeAlD
Olanzapine—CYP2D6—brainstem—intracranial aneurysm	0.00256	0.00275	CbGeAlD
Olanzapine—HTR1B—brain—intracranial aneurysm	0.00234	0.00251	CbGeAlD
Olanzapine—CHRM2—brain—intracranial aneurysm	0.00233	0.0025	CbGeAlD
Olanzapine—HTR1A—cerebellum—intracranial aneurysm	0.00233	0.00249	CbGeAlD
Olanzapine—ADRA2A—medulla oblongata—intracranial aneurysm	0.00231	0.00247	CbGeAlD
Olanzapine—HTR1D—brain—intracranial aneurysm	0.00227	0.00243	CbGeAlD
Olanzapine—HTR2C—brain—intracranial aneurysm	0.00225	0.00241	CbGeAlD
Olanzapine—HTR7—cerebellum—intracranial aneurysm	0.00222	0.00238	CbGeAlD
Olanzapine—ALB—brain—intracranial aneurysm	0.00219	0.00235	CbGeAlD
Olanzapine—ADRA1A—cerebellum—intracranial aneurysm	0.00215	0.0023	CbGeAlD
Olanzapine—CHRM1—brain—intracranial aneurysm	0.00212	0.00227	CbGeAlD
Olanzapine—HTR2B—brain—intracranial aneurysm	0.00211	0.00226	CbGeAlD
Olanzapine—ADRA2A—midbrain—intracranial aneurysm	0.00211	0.00226	CbGeAlD
Olanzapine—DRD2—cerebellum—intracranial aneurysm	0.0021	0.00225	CbGeAlD
Olanzapine—ADRA2C—cerebellum—intracranial aneurysm	0.00204	0.00219	CbGeAlD
Olanzapine—HTR2A—medulla oblongata—intracranial aneurysm	0.00196	0.0021	CbGeAlD
Olanzapine—CHRM3—brain—intracranial aneurysm	0.0019	0.00203	CbGeAlD
Olanzapine—HTR1A—brain—intracranial aneurysm	0.00189	0.00203	CbGeAlD
Olanzapine—HTR7—brain—intracranial aneurysm	0.00181	0.00194	CbGeAlD
Olanzapine—HTR2A—midbrain—intracranial aneurysm	0.00179	0.00192	CbGeAlD
Olanzapine—ADRA1A—brain—intracranial aneurysm	0.00174	0.00187	CbGeAlD
Olanzapine—DRD2—brain—intracranial aneurysm	0.00171	0.00183	CbGeAlD
Olanzapine—ADRA2C—brain—intracranial aneurysm	0.00166	0.00178	CbGeAlD
Olanzapine—ADRA2A—cerebellum—intracranial aneurysm	0.00163	0.00175	CbGeAlD
Olanzapine—HTR2A—cerebellum—intracranial aneurysm	0.00139	0.00149	CbGeAlD
Olanzapine—HRH1—brain—intracranial aneurysm	0.00135	0.00145	CbGeAlD
Olanzapine—ADRA2A—brain—intracranial aneurysm	0.00133	0.00142	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—intracranial aneurysm	0.00129	0.00138	CbGeAlD
Olanzapine—CYP2D6—cerebellum—intracranial aneurysm	0.00126	0.00135	CbGeAlD
Olanzapine—ABCB1—midbrain—intracranial aneurysm	0.00118	0.00126	CbGeAlD
Olanzapine—HTR2A—brain—intracranial aneurysm	0.00113	0.00121	CbGeAlD
Olanzapine—CYP2D6—brain—intracranial aneurysm	0.00103	0.0011	CbGeAlD
Olanzapine—ABCB1—cerebellum—intracranial aneurysm	0.000909	0.000974	CbGeAlD
Olanzapine—ABCB1—brain—intracranial aneurysm	0.000738	0.000791	CbGeAlD
Olanzapine—HTR1E—Signaling Pathways—NCF1—intracranial aneurysm	9.57e-05	0.00143	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—EDNRA—intracranial aneurysm	9.54e-05	0.00143	CbGpPWpGaD
Olanzapine—CHRM4—GPCR ligand binding—CCL2—intracranial aneurysm	9.47e-05	0.00142	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—EDNRA—intracranial aneurysm	9.44e-05	0.00142	CbGpPWpGaD
Olanzapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	9.44e-05	0.00141	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	9.44e-05	0.00141	CbGpPWpGaD
Olanzapine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	9.29e-05	0.00139	CbGpPWpGaD
Olanzapine—HTR2B—GPCR ligand binding—CCL2—intracranial aneurysm	9.16e-05	0.00137	CbGpPWpGaD
Olanzapine—CHRM5—GPCR ligand binding—CCL2—intracranial aneurysm	9.07e-05	0.00136	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—ASAH1—intracranial aneurysm	9.04e-05	0.00136	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—EDNRA—intracranial aneurysm	9.04e-05	0.00135	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—EDNRA—intracranial aneurysm	9e-05	0.00135	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	8.9e-05	0.00133	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—EDNRA—intracranial aneurysm	8.88e-05	0.00133	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—EDNRA—intracranial aneurysm	8.83e-05	0.00132	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	8.82e-05	0.00132	CbGpPWpGaD
Olanzapine—HRH4—Signaling by GPCR—CCL2—intracranial aneurysm	8.66e-05	0.0013	CbGpPWpGaD
Olanzapine—DRD1—GPCR ligand binding—CCL2—intracranial aneurysm	8.64e-05	0.00129	CbGpPWpGaD
Olanzapine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.57e-05	0.00128	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—NCF1—intracranial aneurysm	8.53e-05	0.00128	CbGpPWpGaD
Olanzapine—DRD3—GPCR ligand binding—CCL2—intracranial aneurysm	8.53e-05	0.00128	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	8.52e-05	0.00128	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	8.48e-05	0.00127	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—NCF1—intracranial aneurysm	8.47e-05	0.00127	CbGpPWpGaD
Olanzapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.43e-05	0.00126	CbGpPWpGaD
Olanzapine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.41e-05	0.00126	CbGpPWpGaD
Olanzapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.38e-05	0.00126	CbGpPWpGaD
Olanzapine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.36e-05	0.00125	CbGpPWpGaD
Olanzapine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.28e-05	0.00124	CbGpPWpGaD
Olanzapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	8.25e-05	0.00124	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—CCL2—intracranial aneurysm	8.25e-05	0.00124	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	8.25e-05	0.00124	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TIMP1—intracranial aneurysm	8.15e-05	0.00122	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—EDNRA—intracranial aneurysm	8.11e-05	0.00122	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—EDNRA—intracranial aneurysm	8.05e-05	0.00121	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—EDNRA—intracranial aneurysm	8.02e-05	0.0012	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—EDNRA—intracranial aneurysm	8e-05	0.0012	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—EDNRA—intracranial aneurysm	7.74e-05	0.00116	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—EDNRA—intracranial aneurysm	7.7e-05	0.00115	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR ligand binding—CCL2—intracranial aneurysm	7.7e-05	0.00115	CbGpPWpGaD
Olanzapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	7.67e-05	0.00115	CbGpPWpGaD
Olanzapine—HTR1E—Signaling by GPCR—CCL2—intracranial aneurysm	7.54e-05	0.00113	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	7.54e-05	0.00113	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—EDNRA—intracranial aneurysm	7.49e-05	0.00112	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.48e-05	0.00112	CbGpPWpGaD
Olanzapine—HTR1A—GPCR ligand binding—CCL2—intracranial aneurysm	7.43e-05	0.00111	CbGpPWpGaD
Olanzapine—HTR2C—GPCR ligand binding—CCL2—intracranial aneurysm	7.39e-05	0.00111	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—EDNRA—intracranial aneurysm	7.37e-05	0.0011	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.36e-05	0.0011	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—NOS3—intracranial aneurysm	7.35e-05	0.0011	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.35e-05	0.0011	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.32e-05	0.0011	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.3e-05	0.00109	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.23e-05	0.00108	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	7.21e-05	0.00108	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR ligand binding—CCL2—intracranial aneurysm	7.19e-05	0.00108	CbGpPWpGaD
Olanzapine—ALB—Metabolism—ASAH1—intracranial aneurysm	7.14e-05	0.00107	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR ligand binding—CCL2—intracranial aneurysm	7.08e-05	0.00106	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—EDNRA—intracranial aneurysm	6.79e-05	0.00102	CbGpPWpGaD
Olanzapine—HRH2—Signaling by GPCR—CCL2—intracranial aneurysm	6.72e-05	0.00101	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	6.7e-05	0.001	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—EDNRA—intracranial aneurysm	6.68e-05	0.001	CbGpPWpGaD
Olanzapine—DRD5—Signaling by GPCR—CCL2—intracranial aneurysm	6.67e-05	0.001	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—EDNRA—intracranial aneurysm	6.67e-05	0.001	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—EDNRA—intracranial aneurysm	6.65e-05	0.000996	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—EDNRA—intracranial aneurysm	6.63e-05	0.000993	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—EDNRA—intracranial aneurysm	6.56e-05	0.000984	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—EDNRA—intracranial aneurysm	6.55e-05	0.000981	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—NCF1—intracranial aneurysm	6.54e-05	0.00098	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—NCF1—intracranial aneurysm	6.53e-05	0.000979	CbGpPWpGaD
Olanzapine—DRD2—GPCR ligand binding—CCL2—intracranial aneurysm	6.52e-05	0.000978	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—NCF1—intracranial aneurysm	6.49e-05	0.000972	CbGpPWpGaD
Olanzapine—HTR2A—GPCR ligand binding—CCL2—intracranial aneurysm	6.42e-05	0.000962	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ASAH1—intracranial aneurysm	6.41e-05	0.00096	CbGpPWpGaD
Olanzapine—HRH1—GPCR ligand binding—CCL2—intracranial aneurysm	6.41e-05	0.00096	CbGpPWpGaD
Olanzapine—CHRM1—GPCR ligand binding—CCL2—intracranial aneurysm	6.38e-05	0.000957	CbGpPWpGaD
Olanzapine—CHRM3—GPCR ligand binding—CCL2—intracranial aneurysm	6.36e-05	0.000954	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—NCF1—intracranial aneurysm	6.35e-05	0.000952	CbGpPWpGaD
Olanzapine—CHRM2—GPCR ligand binding—CCL2—intracranial aneurysm	6.3e-05	0.000944	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR ligand binding—CCL2—intracranial aneurysm	6.29e-05	0.000942	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ASAH1—intracranial aneurysm	6.25e-05	0.000937	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—NCF1—intracranial aneurysm	6.25e-05	0.000937	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EDNRA—intracranial aneurysm	6.18e-05	0.000925	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EDNRA—intracranial aneurysm	6.17e-05	0.000924	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—NCF1—intracranial aneurysm	6.17e-05	0.000924	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—NOS3—intracranial aneurysm	6.13e-05	0.000919	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EDNRA—intracranial aneurysm	6.13e-05	0.000918	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—EDNRA—intracranial aneurysm	6.08e-05	0.000911	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EDNRA—intracranial aneurysm	6e-05	0.000899	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—NCF1—intracranial aneurysm	5.97e-05	0.000894	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—NOS3—intracranial aneurysm	5.91e-05	0.000886	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—NCF1—intracranial aneurysm	5.91e-05	0.000885	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EDNRA—intracranial aneurysm	5.9e-05	0.000885	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—MMP9—intracranial aneurysm	5.9e-05	0.000884	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	5.89e-05	0.000883	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	5.84e-05	0.000876	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR ligand binding—CCL2—intracranial aneurysm	5.84e-05	0.000875	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EDNRA—intracranial aneurysm	5.83e-05	0.000873	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	5.82e-05	0.000872	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—NOS3—intracranial aneurysm	5.73e-05	0.000859	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EDNRA—intracranial aneurysm	5.64e-05	0.000845	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—NCF1—intracranial aneurysm	5.63e-05	0.000844	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EDNRA—intracranial aneurysm	5.58e-05	0.000836	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—NCF1—intracranial aneurysm	5.55e-05	0.000832	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EDNRA—intracranial aneurysm	5.32e-05	0.000797	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EDNRA—intracranial aneurysm	5.24e-05	0.000786	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—CCL2—intracranial aneurysm	5.15e-05	0.000772	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—CCL2—intracranial aneurysm	5.15e-05	0.000771	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—CCL2—intracranial aneurysm	5.12e-05	0.000767	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—CCL2—intracranial aneurysm	5.11e-05	0.000766	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—NCF1—intracranial aneurysm	5.01e-05	0.000751	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—CCL2—intracranial aneurysm	5.01e-05	0.00075	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	4.99e-05	0.000748	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—CCL2—intracranial aneurysm	4.93e-05	0.000738	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—CCL2—intracranial aneurysm	4.86e-05	0.000728	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NCF1—intracranial aneurysm	4.84e-05	0.000725	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NCF1—intracranial aneurysm	4.82e-05	0.000722	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EDNRA—intracranial aneurysm	4.74e-05	0.00071	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—CCL2—intracranial aneurysm	4.7e-05	0.000705	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NCF1—intracranial aneurysm	4.68e-05	0.000702	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—NOS3—intracranial aneurysm	4.65e-05	0.000697	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—CCL2—intracranial aneurysm	4.65e-05	0.000697	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NCF1—intracranial aneurysm	4.61e-05	0.000691	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EDNRA—intracranial aneurysm	4.57e-05	0.000685	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—NOS3—intracranial aneurysm	4.56e-05	0.000683	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EDNRA—intracranial aneurysm	4.55e-05	0.000681	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—CCL2—intracranial aneurysm	4.45e-05	0.000668	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—CCL2—intracranial aneurysm	4.43e-05	0.000664	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EDNRA—intracranial aneurysm	4.42e-05	0.000663	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—CCL2—intracranial aneurysm	4.38e-05	0.000656	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EDNRA—intracranial aneurysm	4.35e-05	0.000652	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NCF1—intracranial aneurysm	4.25e-05	0.000637	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NCF1—intracranial aneurysm	4.18e-05	0.000627	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NCF1—intracranial aneurysm	4.17e-05	0.000625	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NCF1—intracranial aneurysm	4.16e-05	0.000623	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NCF1—intracranial aneurysm	4.15e-05	0.000621	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NCF1—intracranial aneurysm	4.11e-05	0.000615	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NCF1—intracranial aneurysm	4.09e-05	0.000614	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EDNRA—intracranial aneurysm	4.01e-05	0.000601	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—NOS3—intracranial aneurysm	3.97e-05	0.000595	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CCL2—intracranial aneurysm	3.97e-05	0.000595	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—CCL2—intracranial aneurysm	3.95e-05	0.000592	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EDNRA—intracranial aneurysm	3.95e-05	0.000592	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CCL2—intracranial aneurysm	3.94e-05	0.000591	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EDNRA—intracranial aneurysm	3.94e-05	0.000591	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EDNRA—intracranial aneurysm	3.93e-05	0.000589	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EDNRA—intracranial aneurysm	3.92e-05	0.000587	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EDNRA—intracranial aneurysm	3.88e-05	0.000581	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EDNRA—intracranial aneurysm	3.87e-05	0.000579	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	3.85e-05	0.000577	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—CCL2—intracranial aneurysm	3.81e-05	0.000571	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NCF1—intracranial aneurysm	3.8e-05	0.00057	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—CCL2—intracranial aneurysm	3.79e-05	0.000568	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—CCL2—intracranial aneurysm	3.69e-05	0.000553	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—NOS3—intracranial aneurysm	3.67e-05	0.00055	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—MMP9—intracranial aneurysm	3.66e-05	0.000548	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—CCL2—intracranial aneurysm	3.63e-05	0.000544	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EDNRA—intracranial aneurysm	3.59e-05	0.000538	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—NOS3—intracranial aneurysm	3.54e-05	0.00053	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—NOS3—intracranial aneurysm	3.51e-05	0.000527	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—CCL2—intracranial aneurysm	3.35e-05	0.000502	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—CCL2—intracranial aneurysm	3.29e-05	0.000494	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—CCL2—intracranial aneurysm	3.29e-05	0.000493	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—CCL2—intracranial aneurysm	3.28e-05	0.000491	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—CCL2—intracranial aneurysm	3.27e-05	0.000489	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—CCL2—intracranial aneurysm	3.23e-05	0.000485	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—CCL2—intracranial aneurysm	3.23e-05	0.000483	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—MMP9—intracranial aneurysm	3.19e-05	0.000477	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CCL2—intracranial aneurysm	3.04e-05	0.000456	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CCL2—intracranial aneurysm	3.04e-05	0.000456	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CCL2—intracranial aneurysm	3.02e-05	0.000453	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—CCL2—intracranial aneurysm	3e-05	0.000449	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CCL2—intracranial aneurysm	2.96e-05	0.000443	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CCL2—intracranial aneurysm	2.91e-05	0.000436	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CCL2—intracranial aneurysm	2.87e-05	0.00043	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MMP9—intracranial aneurysm	2.84e-05	0.000425	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MMP9—intracranial aneurysm	2.82e-05	0.000422	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CCL2—intracranial aneurysm	2.78e-05	0.000416	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CCL2—intracranial aneurysm	2.75e-05	0.000412	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—NOS3—intracranial aneurysm	2.71e-05	0.000406	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—NOS3—intracranial aneurysm	2.71e-05	0.000406	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—NOS3—intracranial aneurysm	2.69e-05	0.000403	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—NOS3—intracranial aneurysm	2.64e-05	0.000395	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CCL2—intracranial aneurysm	2.62e-05	0.000393	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—NOS3—intracranial aneurysm	2.59e-05	0.000389	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CCL2—intracranial aneurysm	2.58e-05	0.000387	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—NOS3—intracranial aneurysm	2.56e-05	0.000383	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—NOS3—intracranial aneurysm	2.48e-05	0.000371	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—NOS3—intracranial aneurysm	2.45e-05	0.000367	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—NOS3—intracranial aneurysm	2.33e-05	0.00035	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CCL2—intracranial aneurysm	2.33e-05	0.00035	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—NOS3—intracranial aneurysm	2.32e-05	0.000348	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—NOS3—intracranial aneurysm	2.3e-05	0.000345	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CCL2—intracranial aneurysm	2.25e-05	0.000338	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CCL2—intracranial aneurysm	2.24e-05	0.000336	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CCL2—intracranial aneurysm	2.18e-05	0.000327	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MMP9—intracranial aneurysm	2.18e-05	0.000326	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MMP9—intracranial aneurysm	2.17e-05	0.000326	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MMP9—intracranial aneurysm	2.16e-05	0.000324	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CCL2—intracranial aneurysm	2.15e-05	0.000321	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MMP9—intracranial aneurysm	2.11e-05	0.000317	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MMP9—intracranial aneurysm	2.08e-05	0.000312	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—NOS3—intracranial aneurysm	2.08e-05	0.000312	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—NOS3—intracranial aneurysm	2.06e-05	0.000308	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MMP9—intracranial aneurysm	2.05e-05	0.000308	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NOS3—intracranial aneurysm	2.01e-05	0.000301	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NOS3—intracranial aneurysm	2e-05	0.000299	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MMP9—intracranial aneurysm	1.99e-05	0.000298	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CCL2—intracranial aneurysm	1.98e-05	0.000296	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—intracranial aneurysm	1.97e-05	0.000295	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCL2—intracranial aneurysm	1.95e-05	0.000292	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NOS3—intracranial aneurysm	1.94e-05	0.000291	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCL2—intracranial aneurysm	1.94e-05	0.000291	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCL2—intracranial aneurysm	1.94e-05	0.00029	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCL2—intracranial aneurysm	1.93e-05	0.000289	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NOS3—intracranial aneurysm	1.91e-05	0.000287	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCL2—intracranial aneurysm	1.91e-05	0.000286	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCL2—intracranial aneurysm	1.91e-05	0.000286	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—NOS3—intracranial aneurysm	1.89e-05	0.000283	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—intracranial aneurysm	1.87e-05	0.000281	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—intracranial aneurysm	1.85e-05	0.000277	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—intracranial aneurysm	1.77e-05	0.000265	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NOS3—intracranial aneurysm	1.76e-05	0.000264	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NOS3—intracranial aneurysm	1.73e-05	0.00026	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NOS3—intracranial aneurysm	1.73e-05	0.000259	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NOS3—intracranial aneurysm	1.73e-05	0.000259	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NOS3—intracranial aneurysm	1.72e-05	0.000258	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NOS3—intracranial aneurysm	1.7e-05	0.000255	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NOS3—intracranial aneurysm	1.7e-05	0.000254	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—intracranial aneurysm	1.67e-05	0.00025	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—intracranial aneurysm	1.61e-05	0.000241	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—intracranial aneurysm	1.6e-05	0.00024	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOS3—intracranial aneurysm	1.58e-05	0.000236	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—intracranial aneurysm	1.56e-05	0.000234	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—intracranial aneurysm	1.53e-05	0.00023	CbGpPWpGaD
Olanzapine—ALB—Metabolism—NOS3—intracranial aneurysm	1.49e-05	0.000223	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—intracranial aneurysm	1.41e-05	0.000212	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—intracranial aneurysm	1.39e-05	0.000209	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—intracranial aneurysm	1.39e-05	0.000208	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—intracranial aneurysm	1.38e-05	0.000207	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—intracranial aneurysm	1.38e-05	0.000207	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—intracranial aneurysm	1.37e-05	0.000205	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—intracranial aneurysm	1.36e-05	0.000204	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—intracranial aneurysm	1.34e-05	0.0002	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—intracranial aneurysm	1.3e-05	0.000196	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—intracranial aneurysm	1.27e-05	0.00019	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—intracranial aneurysm	1.23e-05	0.000184	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—intracranial aneurysm	1.22e-05	0.000183	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—intracranial aneurysm	1.04e-05	0.000156	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—intracranial aneurysm	8.04e-06	0.00012	CbGpPWpGaD
